Back to Journals » Journal of Asthma and Allergy » Volume 18
Evaluating Safety and Effectiveness of Switching Biologics in Managing Severe Asthma Patients [Corrigendum]
Authors Al Awn L, AlAmmari M, AlAbdulkarim D, AlAhmed R, Yadav B, AL-Jahdali H
Received 23 August 2025
Accepted for publication 23 August 2025
Published 5 September 2025 Volume 2025:18 Pages 1253—1254
Al Awn L, AlAmmari M, AlAbdulkarim D, AlAhmed R, Yadav B, AL-Jahdali H. J Asthma Allerg. 2025;18:1161—1166.
Page 1161, Abstract, Results, line 4, the text “the mean number of exacerbations decreased after switching to a different biologic (6.6 vs 3.9, p = 0.1)” should read “the median number of exacerbations decreased after switching to a different biologic (4 vs 2, p = 0.1)”.
The authors apologize for this oversight.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.